ALCAM and breast cancer: In contrast, increased expression of Wnt5a-induced expression of activated leukocyte cell adhesion (ALCAM) effectively stimulates expression of migratory capacity of estrogen receptor- (ER-) positive breast cancer, which leads to enhance clinicopathologic factors involved in breast cancer, including lymph node metastasis, nuclear grade, and lymphatic invasion [36].